BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mu F, Hu LS, Xu K, Zhao Z, Yang BC, Wang YM, Guo K, Shi JH, Lv Y, Wang B. Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome. World J Gastrointest Oncol 2024; 16(5): 1833-1848 [PMID: PMC11099449 DOI: 10.4251/wjgo.v16.i5.1833]
URL: https://www.wjgnet.com/1948-5204/full/v16/i5/1833.htm
Number Citing Articles
1
Vishal G Shelat. Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapyWorld Journal of Gastrointestinal Oncology 2024; 16(10): 4037-4041 doi: 10.4251/wjgo.v16.i10.4037
2
Hui Wan, Yu-Xin Zhang, Guan-Yue Shan, Jun-Ya Cheng, Duan-Rui Qiao, Yi-Ying Liu, Wen-Na Shi, Hai-Jun Li. Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2025; 17(1): 93983 doi: 10.4251/wjgo.v17.i1.93983